We assist clients with their legal needs, from major litigation to financing to trademark and patent registration.

The World Intellectual Property Organization ("WIPO") has recently announced a new global awards program directed towards small and medium sized enterprises.

We previously reported that the Federal Court dismissed a Patented Medicines (Notice of Compliance) (PMNOC) Regulations application relating to Apotex's generic aripiprazole product...

On February 19, 2019, the Patented Medicine Prices Review Board (PMPRB) announced the publication of the 2017 edition of Meds Entry Watch.

The US Court of Appeals for the Federal Circuit denied Microsoft’s petition for a full panel of judges to rehear its appeal in its patent dispute with i4i LP.

As previously reported, the Federal Court of Appeal (FCA) allowed in part Apotex's appeal of a decision awarding Eli Lilly over $100 million for Apotex's infringement ...

The September 21, 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations (see our article here) introduced a new scheme for pharmaceutical patent linkage litigation in Canada.

The Canadian Intellectual Property Office has provided on its website a list of performance targets for its services for the year 2020-2021.

On June 9th, the Canadian Intellectual Property Office ("CIPO") published an updated notice that in response to the COVID-19 pandemic, deadlines falling between March 16th and July 3rd are...

The Canadian Intellectual Property Office has just published notice of its decision to further extend the "designated days" period on account of continuing COVID-19 disruptions.

The Canadian Intellectual Property Office ("CIPO") has released its business strategy for 2023-2028. CIPO's three main priorities are...

The Canadian Intellectual Property Office ("CIPO") has released a preview of its updated version of the Manual of Patent Office Practice ("MOPOP") which will be in force as of October 3rd, 2022.

The Canadian Intellectual Property Office has announced that, effective January 1st, 2020, the fees for certain services associated with geographical indications

Canada and the European Union have established distinct frameworks for extending patent protection beyond standard terms to compensate innovators for regulatory approval delays.

On Wednesday March 25, 2020 the House and Senate passed Bill C-13, an emergency federal bill that provides for compulsory licenses for technologies relating to the health emergency on a time limited basis.

The European Medicines Agency continues to be a leader in developing guidance to industry on biosimilar approvals.

On May 8, 2019, Justice Roy dismissed Servier's application for a prohibition order under the pre-amended Patented Medicines (Notice of Compliance) Regulations for Canadian Patent No

What is intellectual property (IP), and how do you protect it?

On July 10, 2019, the government of Canada published the final version of the new Patent Rules, which will come into force October 30, 2019.

Frédéric Picard brought an application in the Federal Court under subsection 77(1) of the "Official Languages Act" (Act) against the Canadian Intellectual Property Office and the Commissioner of Patents claiming that patents and patent applications must be bilingual to meet the requirements of the legislation.